143 related articles for article (PubMed ID: 12005203)
41. DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs.
Guth BD; Müller TH
Basic Res Cardiol; 1997 Jun; 92(3):181-90. PubMed ID: 9226103
[TBL] [Abstract][Full Text] [Related]
42. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
Herbert JM; Bernat A; Samama M; Maffrand JP
Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
[TBL] [Abstract][Full Text] [Related]
43. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
44. Short-term treatment with nitrate is not sufficient to induce in vivo antithrombotic effects in rats and mice.
Kramkowski K; Leszczynska A; Przyborowski K; Proniewski B; Marcinczyk N; Rykaczewska U; Jarmoc D; Chabielska E; Chlopicki S
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):85-94. PubMed ID: 27743016
[TBL] [Abstract][Full Text] [Related]
45. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
46. Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.
Kawamura M; Imura Y; Moriya N; Kita S; Fukushi H; Sugihara H; Nishikawa K; Terashita Z
J Pharmacol Exp Ther; 1996 Apr; 277(1):502-10. PubMed ID: 8613960
[TBL] [Abstract][Full Text] [Related]
47. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
Kaku S; Kawasaki T; Hisamichi N; Sakai Y; Taniuchi Y; Inagaki O; Yano S; Suzuki K; Terazaki C; Masuho Y; Satoh N; Takenaka T; Yanagi K; Ohshima N
Thromb Haemost; 1996 Apr; 75(4):679-84. PubMed ID: 8743199
[TBL] [Abstract][Full Text] [Related]
48. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
49. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
50. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
51. Antiaggregatory, antithrombotic effects of MS-180, a novel platelet glycoprotein IIb/IIIa receptor antagonist.
Banno H; Kawazura H; Yutaka T; Sakuma N; Kitamori T; Hosoya J; Kibayashi K; Yamashita H; Umemura K; Nakashima M
Eur J Pharmacol; 1999 Feb; 367(2-3):275-82. PubMed ID: 10079002
[TBL] [Abstract][Full Text] [Related]
52. Antithrombotic and antiplatelet activities of Korean red ginseng extract.
Jin YR; Yu JY; Lee JJ; You SH; Chung JH; Noh JY; Im JH; Han XH; Kim TJ; Shin KS; Wee JJ; Yun YP
Basic Clin Pharmacol Toxicol; 2007 Mar; 100(3):170-5. PubMed ID: 17309520
[TBL] [Abstract][Full Text] [Related]
53. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
54. Evaluation on antithrombotic effect of aspirin eugenol ester from the view of platelet aggregation, hemorheology, TXB2/6-keto-PGF1α and blood biochemistry in rat model.
Ma N; Liu XW; Yang YJ; Shen DS; Zhao XL; Mohamed I; Kong XJ; Li JY
BMC Vet Res; 2016 Jun; 12(1):108. PubMed ID: 27296110
[TBL] [Abstract][Full Text] [Related]
55. Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity.
Hernandez MR; Tonda R; Pedreño J; Salas E; Arderiu G; Pino M; Serradell M; Escolar G
J Cardiovasc Med (Hagerstown); 2006 Dec; 7(12):859-65. PubMed ID: 17122671
[TBL] [Abstract][Full Text] [Related]
56. [The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].
Goto J; Muramatsu M; Hosoda K; Otomo S; Aihara H
Nihon Yakurigaku Zasshi; 1984 May; 83(5):395-400. PubMed ID: 6432657
[TBL] [Abstract][Full Text] [Related]
57. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
58. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
[TBL] [Abstract][Full Text] [Related]
59. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Vilahur G; Casaní L; Badimon L
Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
[TBL] [Abstract][Full Text] [Related]
60. Diindolylmethane ameliorates platelet aggregation and thrombosis: In silico, in vitro, and in vivo studies.
Ramakrishna K; Singh N; Krishnamurthy S
Eur J Pharmacol; 2022 Mar; 919():174812. PubMed ID: 35151647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]